Page last updated: 2024-11-05

thalidomide and Anus Diseases

thalidomide has been researched along with Anus Diseases in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Anus Diseases: Diseases involving the ANUS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kolde, G1
Schulze, P1
Sterry, W1
Thomas, L1
Ducros, B1
Secchi, T1
Balme, B1
Moulin, G1

Reviews

1 review available for thalidomide and Anus Diseases

ArticleYear
Successful treatment of adult's Langerhans cell histiocytosis with thalidomide. Report of two cases and literature review.
    Archives of dermatology, 1993, Volume: 129, Issue:10

    Topics: Adolescent; Anus Diseases; Female; Histiocytosis, Langerhans-Cell; Humans; Middle Aged; Skin; Thalid

1993

Other Studies

1 other study available for thalidomide and Anus Diseases

ArticleYear
Mixed response to thalidomide therapy in adults: two cases of multisystem Langerhans' cell histiocytosis.
    Acta dermato-venereologica, 2002, Volume: 82, Issue:5

    Topics: Administration, Oral; Adult; Anus Diseases; Dose-Response Relationship, Drug; Drug Administration Sc

2002